Purdue Pharma told a U.S. bankruptcy judge on Tuesday that it will finalize a new bankruptcy plan in March, with the ...

In an opinion issued on Jan. 24, 2025, on a motion for a stay pending appeal of the court’s decision that a Bankruptcy Code ...

Johnson & Johnson begins a two-week trial on Feb. 18 over its plan to end tens of thousands of lawsuits filed by women or ...

Purdue Pharma’s Sackler family owners are offering to increase their financial contribution to a bankruptcy settlement of opioid lawsuits while accepting some exposure to future litigation ...

On January 24, 2025, the United States Bankruptcy Court for the Eastern District of Virginia entered an opinion denying a motion for a stay pending ...

Purdue Pharma’s owners from the Sackler family ... reopening a path to end the longest and costliest corporate bankruptcy case stemming from the U.S. opioid crisis. The Sackler family members ...

Purdue Pharma planned to exit bankruptcy last year under terms that gave the Sacklers a full release from all civil opioid claims even though they themselves were not declaring bankruptcy.

Purdue Pharma is reported to be preparing to file for bankruptcy amid resistance to its $10-$12 billion offer to settle lawsuits related to the opioid crisis. Several states and cities have ...